To eat or not to eat: dietary fat in uremia is the question.

Although a diet low in protein is well known to reduce the risk of progression in patients with chronic kidney disease (CKD), the impact of dietary fat content and fat quality has largely been ignored. As a reduced protein intake results in an obligatory reduction in energy intake, and as CKD patients often suffer from energy malnutrition, this issue deserves greater attention. The present review aims to summarize what is currently known about dietary fat intake in CKD and suggests areas for further study. We conclude that although overweight per se is an important risk factor for the development of CKD, the role of obesity as a risk factor for complications in manifest CKD remains unclear. Current data support a balanced increase in dietary fat intake in patients with CKD to compensate for reduced energy intake in protein-restricted diets and anorexic patients. However, patients who are obese should be encouraged to lose weight while maintaining or, preferably, increasing muscle mass.

[1]  G. Kiziltan,et al.  Nutrition-related cardiovascular risk factors in hemodialysis patients. , 2010, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[2]  J. Carrero,et al.  Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  A. Tall,et al.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[4]  B. Kestenbaum,et al.  Obesity and change in estimated GFR among older adults. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  P. Schauer,et al.  Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[6]  U. Risérus,et al.  Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[7]  M. Huang,et al.  Measurement of vitamin D in foods and nutritional supplements by liquid chromatography/tandem mass spectrometry. , 2009, Journal of AOAC International.

[8]  M. Laville,et al.  Low protein diets for chronic kidney disease in non diabetic adults. , 2009, The Cochrane database of systematic reviews.

[9]  T. Akizawa,et al.  Vitamin D and vascular calcification in chronic kidney disease. , 2009, Bone.

[10]  B. Rutkowski,et al.  Temporal discrepancies in the association between the apoB/apoA‐I ratio and mortality in incident dialysis patients , 2009, Journal of internal medicine.

[11]  W. Willett,et al.  Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. , 2009, The American journal of clinical nutrition.

[12]  C. Zoccali,et al.  Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. , 2009, Journal of the American College of Cardiology.

[13]  Gert Mayer,et al.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.

[14]  Keith C. Norris,et al.  Reverse Cholesterol Transport Pathway in Experimental Chronic Renal Failure , 2009, American Journal of Nephrology.

[15]  A. Hawasli,et al.  Kidney transplant complications and obesity. , 2009, American journal of surgery.

[16]  F. Dekker,et al.  Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[17]  T. Ikizler Dietary protein restriction in CKD: the debate continues. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  Sun-Hee Park,et al.  Definition of Metabolic Syndrome in Peritoneal Dialysis , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[19]  J. Carrero,et al.  Serum Retinol-Binding Protein Concentration and Its Association with Components of the Uremic Metabolic Syndrome in Nondiabetic Patients with Chronic Kidney Disease Stage 5 , 2008, American Journal of Nephrology.

[20]  J. Axelsson The emerging biology of adipose tissue in chronic kidney disease: from fat to facts. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  T. Ikizler Resolved: being fat is good for dialysis patients: the Godzilla effect: pro. , 2008, Journal of the American Society of Nephrology : JASN.

[22]  M. Czech,et al.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[23]  F. Salvi,et al.  Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans , 2008, Journal of hypertension.

[24]  Peter Stenvinkel,et al.  Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[25]  C. Wanner,et al.  A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. , 2008, Kidney international.

[26]  M. Lazar,et al.  Adipokines and the peripheral and neural control of energy balance. , 2008, Molecular endocrinology.

[27]  B. C. Kwan,et al.  CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: A Story Half Untold: Adiposity, Adipokines and Outcomes in Dialysis Population , 2007, Seminars in dialysis.

[28]  P. Stenvinkel,et al.  Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. , 2007, The American journal of clinical nutrition.

[29]  G. Beck,et al.  Body mass index and mortality in CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  M. Murtaugh,et al.  Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[31]  J. Griffith,et al.  The Framingham predictive instrument in chronic kidney disease. , 2007, Journal of the American College of Cardiology.

[32]  Renée de Mutsert,et al.  Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. , 2007, Journal of the American Society of Nephrology : JASN.

[33]  J. Carrero,et al.  Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  K. Tucker,et al.  alpha-Tocopherol intake and plasma concentration of Hispanic and non-Hispanic white elders is associated with dietary intake pattern. , 2006, The Journal of nutrition.

[35]  F. Lönnqvist,et al.  Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. , 2006, Kidney international.

[36]  P. Kimmel,et al.  Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  W. März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.

[38]  H. Gin,et al.  Carbohydrate metabolism in uraemia , 2005, Current opinion in clinical nutrition and metabolic care.

[39]  R. Cone,et al.  Role of leptin and melanocortin signaling in uremia-associated cachexia. , 2005, The Journal of clinical investigation.

[40]  L. Campbell,et al.  Insulin resistance and postprandial triglyceride levels in primary renal disease. , 2005, Metabolism: clinical and experimental.

[41]  P. Kent Integrating clinical nutrition practice guidelines in chronic kidney disease. , 2005, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[42]  K. Kalantar-Zadeh,et al.  Survival advantages of obesity in dialysis patients. , 2005, The American journal of clinical nutrition.

[43]  L. Niskanen,et al.  Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. , 2005, Archives of internal medicine.

[44]  A. Bello,et al.  Chronic kidney disease: the global challenge , 2005, The Lancet.

[45]  S. Draibe,et al.  Resting energy expenditure of chronic kidney disease patients: influence of renal function and subclinical inflammation. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  S. Draibe,et al.  Decreased resting energy expenditure in non-dialysed chronic kidney disease patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[47]  J. Woo,et al.  Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients. , 2004, Journal of the American Society of Nephrology : JASN.

[48]  P. Stenvinkel,et al.  Truncal fat mass as a contributor to inflammation in end-stage renal disease. , 2004, The American journal of clinical nutrition.

[49]  B. Egan,et al.  Lipids enhance α1-adrenoceptor pressor sensitivity in patients with chronic kidney disease , 2004 .

[50]  F. Lönnqvist,et al.  Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. , 2004, Kidney international.

[51]  S. Beddhu Hypothesis: The Body Mass Index Paradox and an Obesity, Inflammation, and Atherosclerosis Syndrome in Chronic Kidney Disease , 2004, Seminars in dialysis.

[52]  G. Bray,et al.  Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. , 2004, Circulation.

[53]  M. Samore,et al.  Effects of body size and body composition on survival in hemodialysis patients. , 2003, Journal of the American Society of Nephrology : JASN.

[54]  T. Rabelink,et al.  Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms. , 2003, Kidney international. Supplement.

[55]  K. Kalantar-Zadeh,et al.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. , 2003, Kidney international.

[56]  J. Ribaya-Mercado Influence of dietary fat on beta-carotene absorption and bioconversion into vitamin A. , 2002, Nutrition reviews.

[57]  C. Catena,et al.  Abnormalities of glucose metabolism in patients with early renal failure. , 2002, Diabetes.

[58]  N. Vaziri,et al.  Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure. , 2001, Kidney international.

[59]  J W Erdman,et al.  AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. , 2000, Circulation.

[60]  G. Bray,et al.  Dietary fat intake does affect obesity! , 1998, The American journal of clinical nutrition.

[61]  F. Lönnqvist,et al.  Low leptin gene expression and hyperleptinemia in chronic renal failure. , 1998, Kidney international.

[62]  F. Lönnqvist,et al.  Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. , 1997, Journal of the American Society of Nephrology : JASN.

[63]  P. Goldwasser,et al.  Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[64]  G. Reaven,et al.  Effect of chronic renal failure on high-density lipoprotein kinetics. , 1990, Kidney international.

[65]  T. Steinman,et al.  Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. , 1989, Kidney international. Supplement.

[66]  D. Levy,et al.  Cholesterol and mortality. 30 years of follow-up from the Framingham study. , 1987, JAMA.

[67]  J. Kopple,et al.  Energy expenditure in patients with chronic renal failure. , 1986, Kidney international.

[68]  I. Macdougall,et al.  Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[69]  G. Kaysen Lipid and lipoprotein metabolism in chronic kidney disease. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[70]  A. Heng,et al.  Assessment of body protein: energy status in chronic kidney disease. , 2009, Seminars in nephrology.

[71]  K. Kalantar-Zadeh,et al.  Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. , 2007, Journal of the American Society of Nephrology : JASN.

[72]  P. Kris-Etherton,et al.  Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. , 2007, Journal of the American Dietetic Association.

[73]  K. Kalantar-Zadeh,et al.  Association between serum lipids and survival in hemodialysis patients and impact of race. , 2007, Journal of the American Society of Nephrology : JASN.

[74]  S. Draibe,et al.  Is energy intake underestimated in nondialyzed chronic kidney disease patients? , 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[75]  O. Samuelsson,et al.  Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. , 2002, Kidney international.

[76]  E. Ritz,et al.  Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. , 1993, Nephron.